KRAS and colorectal carcinoma: Alterations in cholesterol observed in CRC include the upregulation of ABCA1, which results in poor CRC prognosis via cholesterol transport mechanisms [66], and common KRAS and PIK3CA mutations that lead to accumulation of cholesterol to favour cell proliferation via SREBP activation [68].